| Line item | 2026-03-31 FY | 2025-03-31 FY | 2024-03-31 FY | 2023-03-31 FY | 2022-03-31 FY | 2021-03-31 FY |
|---|---|---|---|---|---|---|
| Revenue | $1.99B | $1.17B | $711.63M | -$67.57M | $1.37B | $787.72M |
| Cost of Revenue | – | – | – | – | – | – |
| Gross Profit | – | – | – | – | – | – |
| Operating Expenses | – | – | – | – | – | – |
| R&D | – | – | – | – | – | – |
| SG&A | $187.25M | $177.35M | $167.32M | $147.16M | $110.47M | $48.48M |
| Operating Income | – | – | – | – | – | – |
| Interest Expense | – | – | $9.33M | $4.19M | $1.11M | $7.36M |
| Tax Expense | -$147.89M | -$49.21M | $27.58M | $3.82M | $28.30M | $23.26M |
| Net Income | -$535.81M | -$179.56M | $58.09M | -$18.40M | $193.88M | $62.63M |
| EPS (basic) | -6.7800 | -2.5200 | 0.9100 | -0.3000 | 3.8900 | 2.1100 |
| EPS (diluted) | -6.7800 | -2.5200 | 0.9100 | -0.3000 | 3.8400 | 2.0600 |
| Shares (diluted) | $79.04M | $71.14M | $66.54M | $61.88M | $53.60M | $33.27M |